(JUNS) Jupiter Neurosciences - Performance -45.9% in 12m
JUNS performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
-33.89%
#91 in Peer-Group
Rel. Strength
12.86%
#6697 in Stock-Universe
Total Return 12m
-45.90%
#156 in Peer-Group
Total Return 5y
-45.90%
#104 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | - |
| High / Low | USD |
|---|---|
| 52 Week High | 15.37 USD |
| 52 Week Low | 0.53 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 81.46 |
| Buy/Sell Signal +-5 | 1.81 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: JUNS (-45.9%) vs XLV (-8.7%)
5y Drawdown (Underwater) Chart
Top Performer in Pharmaceuticals
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| CORT NASDAQ Corcept Therapeutics |
0.72% | 121% | 333% | 62.6 | 55.3 | 0.61 | 23.7% | -5.15% |
| NVS NYSE Novartis |
1.34% | 12.4% | 75.7% | 19.4 | 14.7 | 1.44 | 8.70% | 9.2% |
| LLY NYSE Eli Lilly |
-4.44% | -18.3% | 393% | 64.5 | 36.4 | 1.21 | 58.2% | 18.9% |
| NOVN SW Novartis |
-0.32% | 0.4% | 50.2% | 19.5 | 14.7 | 1.44 | 8.70% | 9.2% |
| GSK NYSE GlaxoSmithKline |
-6.59% | 2.11% | 42.2% | 19.1 | 8.73 | 0.38 | -25.2% | 3.11% |
| IPN PA Ipsen |
0.96% | -4.39% | 39.9% | 25.8 | 10.4 | 0.74 | -6.40% | -6.33% |
| UCB BR UCB |
5.4% | 19.5% | 57.7% | 31.1 | 22 | 1.04 | -22.4% | 39.5% |
| AZN NASDAQ AstraZeneca |
-4.39% | -8.16% | 29.1% | 27.9 | 15.4 | 0.93 | 72.4% | 45.1% |
Performance Comparison: JUNS vs XLV vs S&P 500
XLV (Health Care Sector SPDR ETF) is the Sector Benchmark for JUNS
| Total Return (including Dividends) | JUNS | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | 215.96% | -1.83% | 3.54% |
| 3 Months | 412.07% | -3.24% | 16.07% |
| 12 Months | -45.90% | -8.73% | 12.18% |
| 5 Years | -45.90% | 35.53% | 107.69% |
| Trend Score (consistency of price movement) | JUNS | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | 67.8% | 35.6% | 91.9% |
| 3 Months | 82.1% | -12.6% | 97.5% |
| 12 Months | -44.7% | -80% | 47% |
| 5 Years | -44.7% | 87.5% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XLV | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th99.50 | 221.83% | 205.17% |
| 3 Month | %th100.00 | 429.20% | 341.18% |
| 12 Month | %th23.00 | -40.88% | -47.97% |
| 5 Years | %th56.00 | -40.88% | -47.97% |
FAQs
Does Jupiter Neurosciences (JUNS) outperform the market?
No,
over the last 12 months JUNS made -45.90%, while its related Sector, the Health Care Sector SPDR (XLV) made -8.73%.
Over the last 3 months JUNS made 412.07%, while XLV made -3.24%.
Performance Comparison JUNS vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
JUNS vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 101.8% | 212.4% | -50.6% | -58% |
| US NASDAQ 100 | QQQ | 101.3% | 211.6% | -53% | -59% |
| German DAX 40 | DAX | 102.7% | 214.4% | -61.4% | -75% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 101.2% | 211% | -54.6% | -65% |
| Hongkong Hang Seng | HSI | 101.1% | 213.5% | -72.6% | -80% |
| India NIFTY 50 | INDA | 103.5% | 215.4% | -52% | -43% |
| Brasil Bovespa | EWZ | 106.4% | 218.9% | -62.7% | -46% |
JUNS vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 102.8% | 214.1% | -54.7% | -70% |
| Consumer Discretionary | XLY | 101.4% | 213.4% | -41.9% | -61% |
| Consumer Staples | XLP | 103.6% | 216.7% | -51.3% | -53% |
| Energy | XLE | 103.9% | 216.3% | -40.4% | -44% |
| Financial | XLF | 103.1% | 213.4% | -50.1% | -68% |
| Health Care | XLV | 103.8% | 217.8% | -40.2% | -37% |
| Industrial | XLI | 101.4% | 211.3% | -56.5% | -67% |
| Materials | XLB | 104.3% | 214.3% | -48.4% | -47% |
| Real Estate | XLRE | 102.3% | 216.6% | -49.4% | -52% |
| Technology | XLK | 101.4% | 209.7% | -56.4% | -57% |
| Utilities | XLU | 101% | 214.1% | -53.3% | -67% |
| Aerospace & Defense | XAR | 98.9% | 206.8% | -71.2% | -95% |
| Biotech | XBI | 100.6% | 212.9% | -42% | -32% |
| Homebuilder | XHB | 103.4% | 210.5% | -37.2% | -39% |
| Retail | XRT | 103% | 213.1% | -46.4% | -51% |
JUNS vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | 104.3% | 220% | -34.2% | -40% |
| Natural Gas | UNG | 97.3% | 224.4% | -26.3% | -53% |
| Gold | GLD | 101.2% | 217.6% | -68.2% | -83% |
| Silver | SLV | 99.1% | 212.2% | -67.5% | -68% |
| Copper | CPER | 100.4% | 202.4% | -69.3% | -68% |
JUNS vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 103.2% | 216.1% | -45.1% | -41% |
| iShares High Yield Corp. Bond | HYG | 102.2% | 215.1% | -48.6% | -54% |